санн е тз пим ж т, а л рнъ е еу иа (18, 9 се 27, 3 l/ чс В п еитв, рвеи с ои р ъ ее киъ ст рдц рн
124 patients with schizophrenia 65 years of age, dosing from 5 to 20 mg/ day was not associated with any distinguishing profile of adverse events.